90357314 - PURE-EXO

Information

• Trademark
• 90357314

• Source

• Serial Number

  90357314

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 03, 2020
  4 years ago

• Transaction Date

  October 24, 2024
  a month ago

• Status Date

  October 18, 2024
  a month ago

• Location Date

  October 18, 2024
  a month ago

• Status Code

  645

• Current Location

  TMO LAW OFFICE 121

  Employee Name

  MCCLELLAN, MATTHEW

• Attorney Name

  Janice Housey

  Law Office Assigned Location Code

  N30

• Owners

  • ILIAS BIOLOGICS INC

Case File Statements

• GS0051: Pharmaceutical preparations for treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; drug delivery agents for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications; extracellular vesicles for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biochemicial drug for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; preparations of microorganisms for medical and veterinary use for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; reagents for use in medical genetic testing; diagnostic reagents for medical use; biological preparations for medical or veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological reagents for clinical medical use
• GS0011: Biological preparations, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; proteins for the food industry; chemical reagents, other than for medical or veterinary purpose
• GS0421: Biotechnology research; technological research in the field of cell biology; laboratory research in the field of cell biology; pharmaceutical drug development services; genetic testing for scientific research purposes; research in the field of chemistry; drug discovery services; medical research and development services; pharmaceutical research and development services; biopharmaceutical research and development services

Case File Event Statements

• 12/7/2020 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 2/9/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/20/2021 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/3/2021 - 3 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/3/2021 - 3 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/3/2021 - 3 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/3/2021 - 3 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/3/2021 - 3 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/4/2021 - 3 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/5/2022 - 2 years ago

  10 - SUSPENSION LETTER WRITTEN Type: CNSL

• 1/5/2022 - 2 years ago

  11 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 1/5/2022 - 2 years ago

  12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 7/18/2022 - 2 years ago

  13 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 10/12/2022 - 2 years ago

  14 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 4/18/2023 - a year ago

  15 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 7/6/2023 - a year ago

  16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 2/1/2024 - 10 months ago

  17 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 2/26/2024 - 9 months ago

  18 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 2/26/2024 - 9 months ago

  19 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 2/26/2024 - 9 months ago

  20 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 5/26/2024 - 6 months ago

  21 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 6/24/2024 - 5 months ago

  24 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/24/2024 - 5 months ago

  23 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/24/2024 - 5 months ago

  22 - ASSIGNED TO LIE Type: ALIE

• 10/18/2024 - a month ago

  27 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 10/18/2024 - a month ago

  26 - FINAL REFUSAL E-MAILED Type: GNFR

• 10/18/2024 - a month ago

  25 - FINAL REFUSAL WRITTEN Type: CNFR

• 10/21/2024 - a month ago

  30 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Type: EWOR

• 10/21/2024 - a month ago

  28 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 10/21/2024 - a month ago

  31 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 10/21/2024 - a month ago

  32 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/21/2024 - a month ago

  29 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 10/23/2024 - a month ago

  33 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN